UnknownPhase 2NCT02470689

Diacerin for the Treatment of Epidermolysis Bullosa Simplex

Studying Epidermolysis bullosa simplex

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Tel-Aviv Sourasky Medical Center
Principal Investigator
Eli Sprecher, Prof.
Head of Dermatology Department, Ichilov medical center
Intervention
Diacerin cream(drug)
Enrollment
50 enrolled
Eligibility
6-19 years · All sexes
Timeline
2015

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02470689 on ClinicalTrials.gov

Other trials for Epidermolysis bullosa simplex

Additional recruiting or active studies for the same condition.

See all trials for Epidermolysis bullosa simplex →

← Back to all trials